Switch to:
More From Other Websites
NASH: The next untapped pharma market gives investors many options Apr 24 2017
Trump Executive Order Could Revive Allergan-Pfizer Merger Apr 24 2017
3 Healthcare Bargain Stocks You Can Buy Right Now Apr 24 2017
Novartis’s 1Q17 Estimates for Sandoz Apr 24 2017
Should Gilead Sciences Be Worried About Allergan? Apr 23 2017
Charlie Munger: Loading Up on Leverage Apr 21 2017
Top Analyst Upgrades and Downgrades: Costco, Domino’s Pizza, Fortinet, Verizon, Yum Brands and... Apr 21 2017
Pharma Stock Roundup: J&J Slips on Mixed Q1, Lilly Hit by FDA CRL Apr 21 2017
Allergan Announces 13 Presentations on Chronic Migraine, Upper and Lower Limb Spasticity, Cervical... Apr 20 2017
Chapel Hill company partners with Allergan Apr 20 2017
Allergan Partners with TARGET PharmaSolutions to Advance NASH Research Apr 20 2017
Allergan (AGN) Collaborates with Novartis to Treat NASH Apr 19 2017
[$$] Investors bet on Incyte drug success Apr 19 2017
Allergan, Argentum settle patent dispute over eye drug Restasis Apr 18 2017
Allergan Expands Leading Research & Development NASH Program with Novartis Clinical Collaboration Apr 18 2017
A Healthcare Pick That's Moderately Shielded From Upheaval Apr 17 2017
Why Charlie Munger Hates Value Investing Apr 13 2017
Allergan and Ironwood Launch Campaign Designed to Empower the Nearly 64 Million Americans Estimated... Apr 13 2017
The Real Trump Trade May Be Gold: Cramer's 'Mad Money' Recap (Tuesday 4/11/17) Apr 12 2017
Cramer Remix: Why a slew of IPOs might not be a good thin... Apr 11 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK